Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Results are out on Sedar

<< Previous

Bullboard Posts

Next >>

Comment by Tyrompon Sep 29, 2021 7:20pm

169 Views

Post# 33941443

RE:RE:RE:RE:Results are out on Sedar

Yes, or maybe the revenue from Q2 is moved to Q3? And therefore Q2 should be re-stated

Pandora wrote:

Tyromp wrote: I agree and had the same question

So you're saying if the math was correct the total for 9 months should be
$18,159 + $190,923 + $219,963 = $429,025 and not $238,122 as shown.

Makes a mess of all other numbers then.

Presumably they will shortly be issuing a correction.

Presumably these are not audited.